BR100 Decreased By (-0.4%)
BR30 Decreased By (-0.65%)
KSE100 Decreased By (-0.29%)
KSE30 Decreased By (-0.22%)
AGHA 6.56 Decreased By ▼ -0.11 (-1.65%)
BECO 4.40 Increased By ▲ 0.05 (1.15%)
BML 55.89 Decreased By ▼ -0.28 (-0.5%)
BOP 30.05 Decreased By ▼ -0.07 (-0.23%)
CNERGY 12.75 Decreased By ▼ -0.23 (-1.77%)
CSIL 5.21 Decreased By ▼ -0.10 (-1.88%)
FCCL 51.00 Decreased By ▼ -0.65 (-1.26%)
FFL 14.43 Decreased By ▼ -0.06 (-0.41%)
FNEL 1.22 Increased By ▲ 0.01 (0.83%)
KEL 5.97 Decreased By ▼ -0.09 (-1.49%)
KOSM 5.58 Decreased By ▼ -0.26 (-4.45%)
LOTCHEM 26.15 Decreased By ▼ -0.02 (-0.08%)
MLCF 90.33 Decreased By ▼ -0.90 (-0.99%)
NBP 161.45 Decreased By ▼ -2.74 (-1.67%)
NCPL 52.55 Decreased By ▼ -0.63 (-1.18%)
NPL 57.98 Decreased By ▼ -1.14 (-1.93%)
OGDC 315.40 Increased By ▲ 2.01 (0.64%)
PACE 9.70 Decreased By ▼ -0.07 (-0.72%)
PAEL 34.73 Decreased By ▼ -0.51 (-1.45%)
PIBTL 14.23 Decreased By ▼ -0.48 (-3.26%)
PPL 221.00 Decreased By ▼ -0.36 (-0.16%)
PRL 90.89 Decreased By ▼ -0.33 (-0.36%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.39 Increased By ▲ 0.09 (0.39%)
TBL 8.65 Decreased By ▼ -0.10 (-1.14%)
TELE 7.40 Decreased By ▼ -0.21 (-2.76%)
TPL 21.00 Decreased By ▼ -1.03 (-4.68%)
TPLP 12.02 Decreased By ▼ -0.54 (-4.3%)
TREET 21.33 Decreased By ▼ -0.40 (-1.84%)
TRG 54.35 Decreased By ▼ -1.44 (-2.58%)
Business & Finance

Senegal pays $3.7 mln for 200,000 doses of China's Sinopharm vaccine

  • African nations are struggling to source vaccines in the face of a global scramble for doses.
  • Those include over 620,000 doses of the Pfizer Inc two-shot vaccine at $6.75 per shot, more than 1.2 million of AstraZeneca's two-shot vaccine at $3 each, and nearly 1.5 million of Johnson & Johnson's single-shot vaccine at $10 each.
Published Updated
By

DAKAR: Senegal has paid a little over 2 billion CFA francs ($3.72 million) - or nearly $19 per shot - for 200,000 doses of the COVID-19 vaccine developed by China's Sinopharm, a finance ministry spokesman told Reuters on Friday.

African nations are struggling to source vaccines in the face of a global scramble for doses. Coverage secured through African Union (AU) and World Health Organization-backed (WHO) schemes so far falls short of the continent's needs.

Senegal said in January it was in talks to buy the Chinese vaccine. Finance ministry spokesman Balle Preira confirmed the cost of the shots, which will cover only a fraction of its population of 16 million, without giving further details.

As a lower-middle income country, Senegal is eligible for around 1.3 million doses of AstraZeneca vaccines for free in the first wave of disbursement from the WHO's COVAX scheme.

Separately, the AU says it has secured roughly 670 million shots for the continent. Senegal is eligible to get 3.4 million vaccines for just under $23 million under the plan.

Those include over 620,000 doses of the Pfizer Inc two-shot vaccine at $6.75 per shot, more than 1.2 million of AstraZeneca's two-shot vaccine at $3 each, and nearly 1.5 million of Johnson & Johnson's single-shot vaccine at $10 each.

Senegal's President Macky Sall said this week he aims to start a vaccination campaign by the end of February. The West African nation has recorded about 30,000 cases and 735 deaths from COVID-19 so far.

Despite a relatively late start compared to western vaccine producers, China is ramping up efforts to globally distribute its vaccines.

Chinese and African officials have announced a raft of relatively small vaccine donations to countries, including Equatorial Guinea, Guinea and Congo Republic in recent weeks in what some interpret as an attempt by Beijing to cultivate good will.

Zimbabwe said earlier this week it had purchased 600,000 doses of the Sinopharm vaccine following an initial donation of 200,000 shots. It did not disclose the cost of the deal.

Comments

Comments are closed for this article.